Abstract
To investigate the impact of near-term outcome on survival with concurrent chemotherapy and thoracic three-dimensional radiation therapy for Stage IV non-small cell lung cancer (NSCLC), from a prospective study.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
